RNS
BIIB icon

Robert N. Shapiro’s Biogen BIIB Stock Holding History

Robert N. Shapiro’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$2.23M Sell
6,567
-416
-6% -$135K 0.45% 60
2014
Q3 		$2.31M Buy
6,983
+185
+3% +$61K 0.44% 62
2014
Q2 		$2.14M Sell
6,798
-95
-1% -$28.6K 0.41% 74
2014
Q1 		$2.11M Sell
6,893
-185
-3% -$58.7K 0.39% 76
2013
Q4 		$1.98M Sell
7,078
-60
-0.8% -$15.5K 0.35% 83
2013
Q3 		$1.72M Sell
7,138
-252
-3% -$56.4K 0.3% 106
2013
Q2 		$1.59M Buy
+7,390
New +$1.58M 0.33% 85

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Robert N. Shapiro's BIIB Position: Q4 2014 in Review

Robert N. Shapiro reduced its Biogen (BIIB) stake by 6% in Q4 2014, selling an estimated $135K and leaving 6,567 shares worth $2.23M. The position accounts for 0.45% of the portfolio, ranked #60.

Robert N. Shapiro first reported a position in BIIB in Q2 2013 and has held it in 7 quarters since. The position peaked at $2.31M in Q3 2014. 884 funds tracked by Wall St. Rank hold BIIB as of Q4 2014.

  • Robert N. Shapiro held 6,567 shares of Biogen worth $2.23M as of Q4 2014.
  • Robert N. Shapiro sold 416 Biogen shares in Q4 2014, an estimated $135K.
  • Biogen made up 0.45% of Robert N. Shapiro's portfolio in Q4 2014, its #60 holding.
  • Robert N. Shapiro first reported a position in Biogen in Q2 2013 and has held it in 7 quarters since.
  • Robert N. Shapiro's Biogen position peaked at $2.31M in Q3 2014.
  • 884 funds tracked by Wall St. Rank held Biogen as of Q4 2014.

Based on Robert N. Shapiro's 13F filing for Q4 2014, filed 19 Feb 2015.